Dolby Laboratories (NYSE:DLB) Updates FY 2026 Earnings Guidance

Dolby Laboratories (NYSE:DLBGet Free Report) issued an update on its FY 2026 earnings guidance on Friday morning. The company provided EPS guidance of 4.300-4.450 for the period, compared to the consensus EPS estimate of 3.790. The company issued revenue guidance of $1.4 billion-$1.5 billion, compared to the consensus revenue estimate of $1.4 billion. Dolby Laboratories also updated its Q2 2026 guidance to 1.290-1.440 EPS.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the company. Wall Street Zen raised Dolby Laboratories from a “hold” rating to a “buy” rating in a report on Monday, January 5th. Barrington Research reduced their price target on shares of Dolby Laboratories from $95.00 to $90.00 and set an “outperform” rating for the company in a research note on Monday. Rosenblatt Securities reaffirmed a “buy” rating and issued a $85.00 price objective on shares of Dolby Laboratories in a report on Friday. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Dolby Laboratories in a research report on Monday, December 29th. Three analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $90.75.

Check Out Our Latest Report on DLB

Dolby Laboratories Stock Performance

Shares of NYSE:DLB traded up $0.42 on Friday, reaching $63.45. The company’s stock had a trading volume of 664,402 shares, compared to its average volume of 749,811. The company has a market cap of $6.06 billion, a P/E ratio of 24.16 and a beta of 0.88. Dolby Laboratories has a 52-week low of $60.14 and a 52-week high of $85.49. The company has a 50-day simple moving average of $65.14 and a 200 day simple moving average of $68.95.

Dolby Laboratories (NYSE:DLBGet Free Report) last posted its quarterly earnings data on Thursday, January 29th. The electronics maker reported $1.06 earnings per share for the quarter, beating analysts’ consensus estimates of $0.99 by $0.07. The business had revenue of $346.71 million for the quarter, compared to analysts’ expectations of $341.26 million. Dolby Laboratories had a net margin of 18.90% and a return on equity of 11.99%. The business’s revenue was down 2.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.14 earnings per share. On average, equities research analysts forecast that Dolby Laboratories will post 2.94 EPS for the current fiscal year.

Dolby Laboratories Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, February 18th. Shareholders of record on Tuesday, February 10th will be issued a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a yield of 2.3%. The ex-dividend date is Tuesday, February 10th. Dolby Laboratories’s dividend payout ratio is presently 54.75%.

Insider Buying and Selling

In related news, CEO Kevin J. Yeaman sold 36,699 shares of the stock in a transaction that occurred on Monday, November 24th. The shares were sold at an average price of $66.91, for a total value of $2,455,530.09. Following the completion of the transaction, the chief executive officer directly owned 114,725 shares of the company’s stock, valued at $7,676,249.75. This trade represents a 24.24% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Mark Andrew Sherman sold 9,109 shares of Dolby Laboratories stock in a transaction dated Tuesday, December 16th. The stock was sold at an average price of $66.73, for a total value of $607,843.57. Following the sale, the executive vice president directly owned 73,054 shares of the company’s stock, valued at approximately $4,874,893.42. This represents a 11.09% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 137,120 shares of company stock valued at $9,184,809. 37.93% of the stock is currently owned by insiders.

Trending Headlines about Dolby Laboratories

Here are the key news stories impacting Dolby Laboratories this week:

  • Positive Sentiment: Company raised guidance well above Street estimates — Dolby updated FY?2026 EPS and revenue guidance (FY EPS 4.30–4.45 vs. consensus ~3.79; Q2 EPS and revenue guidance also above estimates), which supports upside to forward earnings expectations. TipRanks: Dolby Reports Q1 Results and Outlook
  • Positive Sentiment: Q1 beat consensus on revenue and EPS on a headline basis — reported revenue (~$346.7M) and non?GAAP EPS (~$1.06) topped estimates, showing near?term operational resilience. Zacks: Q1 Earnings & Revenues Surpass Estimates
  • Positive Sentiment: Dividend declared — quarterly cash dividend of $0.36/share (ex?dividend Feb 10), which supports income-minded holders and signals steady capital return policy. (Company release and investor materials.)
  • Positive Sentiment: Analyst support — Rosenblatt reaffirmed a Buy and $85 price target, underscoring analyst conviction in upside vs. current levels. Benzinga: Rosenblatt Reaffirms Buy
  • Neutral Sentiment: Company commentary and transcripts available — management presented a confident tone on market position during the earnings call; full transcript and press release provide detail for investors doing due diligence. PR Newswire: Q1 Financial Results Seeking Alpha: Earnings Call Transcript
  • Neutral Sentiment: Analyst commentary/upgrades are mixed — some outlets call the quarter “solid” and note improved valuation after results; useful for longer?term thesis rather than immediate price action. Seeking Alpha: Solid Q1 — Upgrade
  • Negative Sentiment: Revenue fell year?over?year and licensing weakness drove investor concern — despite the beats, total revenue declined YoY and licensing trends were cited as a drag, which pressured sentiment after the release. Zacks: Sales Fall Y/Y, Licensing Weakness
  • Negative Sentiment: Profitability and cash?flow metrics showed pressure in the quarter — third?party summaries highlighted operating profit, net income and operating cash flow declines that amplify near?term risk, contributing to a roughly 3% after?hours selloff. QuiverQuant: Details on Profitability and Cash Flow
  • Negative Sentiment: Insider selling and mixed institutional flows noted in data services — some investors may interpret recent insider sales and portfolio reallocations as a cautionary sign. QuiverQuant: Insider & Institutional Activity

Institutional Investors Weigh In On Dolby Laboratories

Several hedge funds have recently modified their holdings of the company. Aquatic Capital Management LLC purchased a new position in shares of Dolby Laboratories during the 3rd quarter worth approximately $56,000. iSAM Funds UK Ltd purchased a new stake in Dolby Laboratories during the 3rd quarter worth about $68,000. Advisory Services Network LLC acquired a new stake in Dolby Laboratories in the third quarter valued at approximately $102,000. US Bancorp DE raised its holdings in shares of Dolby Laboratories by 31.3% in the 3rd quarter. US Bancorp DE now owns 1,429 shares of the electronics maker’s stock valued at $103,000 after purchasing an additional 341 shares in the last quarter. Finally, EverSource Wealth Advisors LLC lifted its holdings in Dolby Laboratories by 273.3% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,598 shares of the electronics maker’s stock worth $193,000 after buying an additional 1,902 shares during the last quarter. 58.56% of the stock is owned by hedge funds and other institutional investors.

Dolby Laboratories Company Profile

(Get Free Report)

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.

Further Reading

Earnings History and Estimates for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.